AMENDMENTTO DEBENTURE OF FIXED CHARGE
Exhibit 10.4
AMENDMENT TO DEBENTURE OF FIXED CHARGE
This amendment (the “Amendment”) to the Debenture of Fixed Charge dated October 23, 2013, as amended, modified, restated, replaced or supplemented and as may be further amended, modified, restated, replaced or supplemented from time to time in accordance with its terms (the “Debenture”) is made as of June 13, 2016 by and among Inspire M.D Ltd., a limited liability company organised and existing under the laws of the State of Israel with its registered office at 4 Menorat Hamaor St., Tel Aviv, 6744831, Israel, company number 51-367943-1 (the “Pledgor”), and Hercules Capital, Inc., a Maryland corporation with its registered office at 400 Hamilton Avenue, Suite 310, Palo Alto, California 94301 (the “Lender”) and Hercules Capital, Inc., a Maryland corporation with its registered office at 400 Hamilton Avenue, Suite 310, Palo Alto, California 94301 in its capacity as administrative agent for itself and the Lenders under the Loan Agreement (in such capacity, the “Agent”). All terms capitalized and not otherwise defined hereunder shall have the meanings assigned to such terms under the Debenture.
WHEREAS, the Lender, the Pledgor and the its parent company InspireMD, Inc. have entered into that certain loan arrangement dated as of October 23, 2013, evidenced by, among other documents, a certain Loan and Security Agreement dated as of October 23, 2013 (hereinafter, as may be amended, restated, replaced or supplemented from time to time in accordance with its terms, and together with the Loan Documents (as defined thereunder), collectively, the “Loan Agreement”) and in connection with that Loan Agreement, the Pledgor and the Lender wish to amend the provisions of the Debenture as set forth herein.
NOW THEREFORE, the Parties agree as follows:
1. | Description of Change in Terms: |
A. | The first paragraph of the preamble shall be replaced in its entirety with the following: |
“WHEREAS, the undersigned, Inspire M.D Ltd, a limited liability company organised and existing under the laws of the State of Israel with its registered office at 4 Menorat Hamaor St., Tel Aviv, 6744831, Israel (hereinafter: the “Pledgor”), intends to receive, jointly and severally with its parent company, InspireMD, Inc. (hereinafter: the “Parent”) from several banks and other financial institutions or entities from time to time parties to the Loan Agreement (as defined below) (collectively, the “Lender”), including Hercules Capital, Inc., a Maryland corporation with its registered office at 400 Hamilton Avenue, Suite 310, Palo Alto, California 94301 in its capacity as administrative agent for itself and the Lenders (in such capacity, the “Agent”), a loan or loans, for such purpose and on such conditions as specified in the provisions of that certain Loan and Security Agreement entered into between and among the Lenders, the Pledgor and the Parent on October 23rd, 2013, as amended from time to time (hereinafter, as may be amended, restated, replaced or supplemented from time to time in accordance with its terms, and together with the Loan Documents (as defined thereunder), collectively, the “Loan Agreement”);”
B. | Section 2 of the Debenture shall be replaced in its entirety with the following: |
" 2. As collateral security for the full and punctual payment of all of the Secured Sums (whether at stated maturity, acceleration or otherwise), and without derogating from any other security, the Pledgor hereby absolutely and unconditionally charges and pledges to the Lender and its successors by way of a first ranking fixed charge and pledge, and by an assignment by way of pledge, as applicable, (A) (i) all Pledgor's rights to receive funds from its customers listed under Appendix A attached hereto (the “Customers List”), and (ii) each outstanding account as specified in Appendix B attached hereto (the “Pledged Accounts”), and (B) all Pledgor's rights, whether now existing or thereafter created (i) in and to all copyright rights, copyright applications, copyright registrations and like protections in each work of authorship and derivative work thereof, whether published or unpublished, and whether or not the same also constitutes a trade secret, now or hereafter existing, created, acquired or held (“Copyrights”), including without limitation as specified in Appendix C attached hereto; (ii) in and to all patents, patent applications and like protections, including without limitation improvements, divisions, continuations, renewals, reissues, extensions, and continuations-in-part of the same (“Patents”), including without limitation as specified in Appendix D attached hereto; (iii) in and to all trademark and service mark rights, whether registered or not, applications to register and registrations of the same and like protections, and the entire goodwill of the business of Pledgor connected with and symbolized by such trademarks (“Trademarks”), including without limitation as specified in Appendix E attached hereto; (iv) in and to all mask works or similar rights available for the protection of semiconductor chips, now owned or hereafter acquired (“Mask Works”), including, without limitation as specified in Appendix F; (v) in and to all trade secrets and trade secret rights, including, without limitation, any rights to unpatented inventions, know-how, operating manuals; (vi) in and to all source code; (vii) in and to all design rights; (viii) in and to all claims for damages by way of past, present and future infringement of any of the foregoing, with the right, but not the obligation, to sue for and collect such damages for said use or infringement of the intellectual property rights identified above; and (ix) in and to all trade secrets, and any and all intellectual property rights in computer software and computer software products now or hereafter existing, created, acquired or held; (x) in and to all amendments, renewals and extensions of any of the Copyrights, Trademarks, Patents and Mask Works; in all cases whether now owned or hereafter acquired by Pledgor; (xi) in and to all licenses or other rights to use any of the Copyrights, Patents, Trademarks, or Mask Works and all license fees and royalties arising from such use to the extent permitted by such license or rights; (xii) to all proceeds and products of the foregoing, including, without limitation, all payments under insurance or any indemnity or warranty payable in respect of any of the foregoing; and (C) all the fixed assets listed under Appendix G (the “Equipment List”) (hereinafter (A), (B) and (C), jointly and severally, the "Charged Property”).
It is hereby agreed and acknowledged that the description of the Charged Property, including without limitations, the Customers List, Pledged Accounts, Copyrights, Patents, Trademarks, Mask Works and Equipment List, shall be amended and updated from time to time by the Pledgor, in accordance with the provisions hereof and the provisions of the Loan Agreement."
C. | The following shall be added as Section 33 of the Debenture: |
" AGENCY
33. Lenders hereby irrevocably appoints Hercules Capital, Inc. to act on their behalf as the administrative agent for itself and the Lenders (in such capacity, the “Agent”) hereunder and authorizes the Agent to take such actions on its behalf and to exercise such powers as are delegated to the Agent by the terms hereof or thereof, together with such actions and powers as are reasonably incidental thereto. It is hereby noted that all rights granted herein to the Lender shall be deemed as granted to the Agent for the ratable benefit of the Lenders.”
2. | The above mentioned Appendixes shall be attached hereto as integral part hereof and as integral part of the Debenture. |
3. | Except as specifically set forth herein, none of the terms of the Debenture shall be in any way modified by this Amendment, and all such terms and conditions shall remain in full force and effect. |
4. | This Addendum is made in accordance with Section 29 of the Debenture, and constitutes (together with any appendix attached hereof) an integral part thereof. |
-signature page follows-
IN WITNESS WHEREOF, the parties have caused this Amendment to be signed on the date first above written.
/s/ Ben Bang | ||
HERCULES CAPITAL, INC. [also in its capacity as Agent] | ||
By: | Ben Bang | |
Title: | Associate General Counsel | |
/s/ Craig Shore | ||
INSPIRE M.D LTD | ||
By: | Craig Shore | |
Title: | CFO |
Appendix A
Customers List
Company | Country | |
CMS Produtos Medicos Ltda (OLD) | Brazil | |
Dispomed Promet | Croatia | |
Medreto OU | Estonia | |
Dr. Osypka GmbH | Germany | |
Tzamal Jakobsohn Ltd | Israel | |
KIRLOSKAR TECHNOLOGIES (P) LTD | India | |
Euromed GmbH | Austria | |
Sigma Medical B.V. | Netherlands | |
Bosti Trading Ltd. | Cyprus | |
Dream Technology L.P. | United Kingdom | |
Charles de Giorgio Ltd. | Malta | |
Premier G. Med Cardio Ltd | Hungary | |
Torque Medical | South Africa | |
Stimcare | Czech Republic | |
Fortimed | Spain | |
Grex Medical Oy | Finland | |
Tecmed SRL | Romania | |
Vascular Perspectives Ltd | United Kingdom | |
Meliora Medtech AB | Sweden | |
lnselspital Bern | Switzerland | |
Hospital Fribourgeols | Switzerland | |
Chi Le Raincy Montfermeil | France | |
Groupe Hospitalier Mutualiste | France | |
CHUV | Switzerland | |
Bay Medical Pty Ltd | Australia | |
CENTRE HOSPITALIER D AVIGNON | France | |
GlobalMed a.s. | Slovakia | |
Universitatsmedizin Rostock | Germany | |
CMS Chile | Chile | |
CHU Besancon (not active) | France | |
CH Haguenau | France | |
PLN Szpital Uniwersytecki w Krakowie | Poland | |
Katedra i Klinika Kardiologii Uniwersytetu Medyc | Poland | |
University Hospitals Southampton NHS Foundation | United Kingdom | |
Vingmed AS. Norway | Norway | |
KAUF Klinikum Fulda gAG | Germany | |
Clinique Pasteur | France | |
SLK Kliniken Heilbronn GmbH | Germany | |
Centre Hospitalier de la region Anneciennc | France | |
Charite - Universitatsmedizin Berlin - CVK | Germany | |
Kardiologische Praxis Prof. Dr. Silber | Germany |
1
lnstitut Jacques Cartier | France | |
HJK Erkelenz/Am Schneller | Germany | |
Centre Hospitalier de LA CAVALE BLANCHE | France | |
CHU Jean Minjoz Besancon | France | |
SPZOZ, Pracownia Hemodynamiki | Poland | |
Waldkrankenhaus | Germany | |
SAS CLINIQUE GENERALE DE MARIGNANE | France | |
Antwerp Cardiovascular Institute, AZ Middelheim | Belgium | |
G.C.S. Cardio CHRA | France | |
Krakowskie Centrum Kardiologii | Poland | |
CHU Gabriel Montpied | France | |
Clinique Saint-Vincent | France | |
Sana-Herzzentrum Cottbus GmbH | Germany | |
Herzzentrum Dresden GmbH | Germany | |
Cardiology Associates of North MS/Research, LLC | United States | |
SIA Scanmed | Latvia | |
CARDIO MEDICAL D.O.O. | Slovenia | |
Unfallkrankenhaus Berlin | Germany | |
Vingmcd Sweden | Sweden | |
polyclinique des fleurs | France | |
Medilex Limited | Ireland | |
Hopital Claude Galien ICPS | France | |
Sz.P. Wieslaw Mazurek | Poland | |
Hopital haut leveque-CHU de Bordeaux | France | |
CHU de Toulouse hopital de Rangueil | France | |
Kardia | Italy | |
Uniwersytecki Szpital Kliniczny | Poland | |
Avidal Group GMBH | Germany | |
JSC Medikamcntu tinklas Co. | Lithuania | |
HELIOS Klinikum Aue | Germany | |
Uniwersyteckie Centrum Kliniczne | Poland | |
Wojskowym Instytutem Medycznym | Poland | |
Izasa Hospital SLU | Spain | |
Uniwersytetu Medycznego w Lodzi | Poland | |
Klinika Kardiologii i Angiologii Interwencyjnej | Poland | |
Charite Universitatsklinikum Berlin Campus Virch | Germany | |
Charite Universitatsklinikum Berlin Campus Benja | Germany | |
Cardiff University Hospitals | United Kingdom | |
Sheffield Teaching Hospitals | United Kingdom | |
Universitatsklinikum Magdeburg A.o.R. | Germany | |
Petr Jerabek | Czech Republic | |
Jan Winten | Belgium | |
Christopher MacLeod | United Kingdom | |
Miki Olsher | Israel | |
Stephane Viney | France | |
Vivianc Barbieri | Brazil |
2
Dominika Chudzik | Poland | |
Eduard Kasper | Germany | |
Paul Jeffers | United Kingdom | |
Jane Bettoni | Italy | |
Sieglinde Reik-Lingen | Germany | |
Piet van den Bosch | Netherlands | |
Juan Rigla | Spain | |
Kim Vandeweyer | Belgium | |
Rick Olson | United Kingdom | |
Pavel Minkov | Israel | |
Ralph Essers | Netherlands | |
Jens Ten Doornkaat | Germany | |
Giancarlo Fasulo | Italy | |
TIP Profiles Karolina Mendocha | Poland | |
Augusta-Krankcnhaus VKKD | Germany | |
Logis-Med Sp. Zo.o. | Poland | |
VASMO Medical Group | Poland | |
Centre Hospitalier St. Joseph et st Luc 2 | France | |
Avidal Group GMBH as Agent | Germany | |
Klinikum Stadt Soest | Germany | |
Herz- und Diabeteszentrum NRW | Germany | |
Manchester Royal Infirmary | United Kingdom | |
Austro Line d.o.o. | Monaco | |
I.R.C.C.S. Policlinico San Donato | Italy | |
Azienda ULSS 13 MIRANO Regione Veneta | Italy | |
Hairmyres NHS Trust OCT | United Kingdom | |
Sheba Medical Center | Israel | |
Stefano Cova | Italy | |
Herzklinik Dres Harer | Germany | |
Sunderland Hospital | United Kingdom | |
CARDIO MEDICAL SALES L.P. | Lithuania | |
Nathalie Barthelemy | France | |
MCZ-Hemodynamika | Poland | |
Kaster Srl | Italy | |
Norfolk and Norwich University Hospital- OCT | United Kingdom | |
Morriston Hospital- OCT | United Kingdom | |
Papworth Hospital NHS Foundation Trust- OCT | United Kingdom | |
University Hospitals of South Manchester- OCT | United Kingdom | |
Hairmyres NHS Trust | United Kingdom | |
Freeman Hospital | United Kingdom | |
SAMODZIELNY PUBLICZNY ZOZ WOJE | Poland | |
Shaare Zedek Medical Center | Israel | |
מ”עבעשירא | Israel | |
CROSSMED S.r.1. | Italy | |
Carlos Haya Hospital | Spain | |
LMR A.O.U. Citta delta Salute e della | Italy |
3
LMR Ospedale Policlinico Santa Maria | Italy | |
Cyvital Enterprises Limited | Cyprus | |
Piotr Musialek | Poland | |
ULSS 13 Mirano - Presidio de Mirano - LMR | Italy | |
Pauls Stradins Clinical University Hospital -LMR | Latvia | |
VIDE BULA | Brazil | |
E-Symbion SRL | Romania | |
ProCardia Medical Sp. z o.o. | Poland | |
Carmel Medical Center | Israel | |
Prof. Schofer | Poland | |
Rothschild Hospital | France | |
CHU Grenoble | France | |
INMED Com. de Mat. Hosp. Ltda | Brazil | |
INTUIT | Brazil | |
TECNOMEDICAL | Brazil | |
Somma Produtos Hospitalares LTDA | Brazil | |
Penumbra Europe GmbH | Germany | |
Endovix | Brazil | |
The Queen Elizabeth University Hospital | United Kingdom | |
SUPRI Medical and Hospital Devices Ltda | Brazil | |
WORLD MEDICAL S.A.S. | Colombia | |
lmportadora y Exportadora CAMIR LTDA | Chile | |
Pro Gem | Slovenia | |
Osypka AG | Germany | |
Barts and The London NHS Trust | United Kingdom | |
Med-All International | Germany | |
Mediscape | Malaysia | |
Angiocor S.A. | Argentina | |
Svelte Medical Systems, Inc. | United States | |
EURO MEKO | Germany | |
QUALIMED | Germany | |
BCH | Canada | |
Natec Medical Ltd. | Mauritius | |
Cardiovascular Interventional Concepts (CIC) | Brazil | |
LEVBETH MEDICAL SA DE CV | Mexico | |
MedlineS Kft. | Hungary | |
KEBOMED AS | Denmark | |
Endo Tech s.r.o | Czech Republic |
[END OF EXHIBIT A]
4
Appendix B
Pledged Accounts
Det Trial Bal: Acct Curr & USD
6/8/2016
Curr | Account No. | Account Description | Balance (ILS) | Bal (USD) | Bal (Acct Curr) | Curr | ||||||||||||||
1**.ASSETS | ||||||||||||||||||||
10*.CURRENT ASSETS | ||||||||||||||||||||
104.Accounts Receivable- Clients | ||||||||||||||||||||
100021 | Tzamal Jakobsohn Ltd | 243,941.71 | 64,338.97 | |||||||||||||||||
Total | 243,941.71 | 64,338.97 | 0 | |||||||||||||||||
CHF | 100068 | CHUV | 3,746.60 | 996.17 | 963.36 | CHF | ||||||||||||||
Total | 3,746.60 | 996.17 | 963.36 | CHF | ||||||||||||||||
EUR | 100015 | Medreto OU | 1,711.52 | 453.98 | 400 | EUR | ||||||||||||||
100036 | Bosti Trading Ltd. | -31,014.72 | -8,246.40 | -7,260.51 | EUR | |||||||||||||||
100054 | Torque Medical | -137.76 | -17.98 | EUR | ||||||||||||||||
100057 | Grex Medical Oy | -427.17 | -113.58 | -100 | EUR | |||||||||||||||
100058 | Tecmed SRL | 22,499.75 | 5,929.17 | 5,250.00 | EUR | |||||||||||||||
100071 | GlobalMed a.s. | 30,772.13 | 8,093.11 | 7,145.00 | EUR | |||||||||||||||
100097 | Institut Jacques Cartier | 5,094.19 | 1,347.06 | 1,185.78 | EUR | |||||||||||||||
100121 | G.C.S. Cardio CHRA | 9,256.31 | 2,467.07 | 2,171.56 | EUR | |||||||||||||||
100137 | polyclinique des fleurs | -115.81 | -30.79 | -27.11 | EUR | |||||||||||||||
100139 | Hopital Claude Galien ICPS | 4,210.96 | 1,119.64 | 985.78 | EUR | |||||||||||||||
100142 | Hopital haut leveque-CHU de Bordeaux | 4,168.82 | 1,119.50 | 985.78 | EUR | |||||||||||||||
100144 | Kardia | 67,940.45 | 18,064.46 | 15,904.78 | EUR | |||||||||||||||
100146 | Avidal Group GMBH | 80,372.52 | 20,931.35 | 18,700.00 | EUR | |||||||||||||||
100159 | Izasa Hospital SLU | 108,984.02 | 28,689.59 | 25,320.00 | EUR | |||||||||||||||
100229 | Centre Hospitalier St. Joseph et st Luc 2 | 2,121.10 | 560.55 | 492.89 | EUR | |||||||||||||||
100230 | Avidal Group GMBH as Agent | 2,801.51 | 716.5 | 658.45 | EUR | |||||||||||||||
100249 | Kaster Srl | 124,500.75 | 33,366.48 | 29,150.00 | EUR | |||||||||||||||
100262 | CROSSMED S.r.l. | 118,126.56 | 30,948.36 | 27,360.00 | EUR | |||||||||||||||
100266 | Cyvital Enterprises Limited | 6,806.32 | 1,820.58 | 1,600.00 | EUR | |||||||||||||||
100293 | MedlineS Kft. | -3,359.23 | -736.02 | -786.53 | EUR | |||||||||||||||
100295 | Endo Tech s.r.o | -59.9 | -14.42 | EUR | ||||||||||||||||
Total | 554,252.32 | 146,468.21 | 129,135.87 | EUR | ||||||||||||||||
GBP | 100254 | Hairmyres NHS Trust | 118.43 | 31.49 | 21.59 | GBP | ||||||||||||||
100255 | Freeman Hospital | -3,250.20 | -831.25 | -600 | GBP | |||||||||||||||
100297 | Asteral Services Ltd | 428.05 | 114.24 | 78 | GBP | |||||||||||||||
Total | -2,703.72 | -685.52 | -500.41 | GBP | ||||||||||||||||
PLN | 100227 | Logis-Med Sp. Z o.o. | -7,209.62 | -1,843.89 | -7,250.00 | PLN | ||||||||||||||
Total | -7,209.62 | -1,843.89 | -7,250.00 | PLN | ||||||||||||||||
USD | 100050 | Temp USD | -165.48 | -44 | -44 | USD | ||||||||||||||
100129 | SIA Scanmed | 31,451.49 | 8,237.50 | 8,237.50 | USD | |||||||||||||||
100243 | CARDIO MEDICAL SALES L.P | 525,895.00 | 134,500.00 | 134,500.00 | USD | |||||||||||||||
100285 | Penumbra Europe GmbH | 132,652.31 | 30,615.00 | 30,615.00 | USD | |||||||||||||||
100288 | SUPRI Medical and Hospital Devices Ltda | -166.95 | 0 | USD | ||||||||||||||||
100291 | Cardiovascular Interventional Concepts (CIC) | 133 | 0 | USD | ||||||||||||||||
100292 | LEVBETH MEDICAL SA DE CV | 4,270.20 | 0 | USD | ||||||||||||||||
100294 | KEBOMED AS | 43,968.65 | 11,000.00 | 11,000.00 | USD | |||||||||||||||
207136 | provision for returns | 75.22 | 20 | 20 | USD | |||||||||||||||
300023 | Angiocor S.A | 102,527.00 | 27,000.00 | 27,000.00 | USD | |||||||||||||||
Total | 840,640.44 | 211,328.50 | 211,328.50 | USD | ||||||||||||||||
105.Accounts Receivable- Doubtful | ||||||||||||||||||||
EUR | 100027 | Novalab France | 266,498.55 | 70,858.43 | 62,387.00 | EUR | ||||||||||||||
100028 | Euromed Deutschland GmbH | 748,246.48 | 198,948.81 | 175,163.63 | EUR | |||||||||||||||
100029 | Euromed GmbH | 23,921.52 | 6,360.41 | 5,600.00 | EUR | |||||||||||||||
100034 | Slainte Solutions Ltd | 62,443.71 | 16,602.95 | 14,618.00 | EUR | |||||||||||||||
101111 | Provision for bad debts Euro | -1,101,239.86 | -292,805.07 | -257,798.97 | EUR | |||||||||||||||
Total | -129.6 | -34.47 | -30.34 | EUR | ||||||||||||||||
GBP | 100190 | Cardiff University Hospitals | 3,016.86 | 802.14 | 550 | GBP | ||||||||||||||
101112 | Provision for bad debts GBP | -3,016.86 | -802.14 | -550 | GBP | |||||||||||||||
Total | 0 | 0 | 0 | GBP | ||||||||||||||||
USD | 100273 | E-Symbion SRL | 18,924.14 | 5,021.00 | 5,021.00 | USD | ||||||||||||||
101113 | Provision for bad debts $ | -18,883.98 | -5,021.00 | -5,021.00 | USD | |||||||||||||||
Total | 40.16 | 0 | 0 | USD | ||||||||||||||||
TOTAL | 1,632,578.29 | 420,567.97 | USD |
Appendix C
Copyrights
None.
Appendix D
Patents
Description | Registration/ Application Number (Country) | Registration/ Application Date | ||
Optimized Stent Jacket | 198,665 (IL) | Nov. 21, 2007; issued May 28, 2014 | ||
Optimized Stent Jacket | ZL200780043259.2 (CN) | Nov. 21, 2007; issued Jan. 2, 2013 | ||
Optimized Drug-Eluting Stent Assembly | 9,132,003 (US); 14/314,777 | June 24, 2014; issued Jan. 2, 2013 | ||
Optimized Stent Jacket | ZL201210454357.8 (CN) | Nov. 13, 2013; issued Dec. 9, 2015 | ||
Bifurcated Stent Assemblies | 198,188 (IL) | Oct. 18, 2007; issued May 1, 2014 | ||
In Vivo Filter Assembly | 8,043,323 (US); 11/582,354 | Oct. 18, 2006; issued Oct. 25, 2011 | ||
Bifurcated Stent Assemblies | 8,961,586 (US); 11/797,168 | May 1, 2007; issued Feb. 24, 2015 | ||
In Vivo Filter Assembly | 9,132,261 (US); 13/237,977 | Sept. 21, 2011; issued Sept. 15, 2015 | ||
Bifurcated Stent Assemblies | ZL200780046676.2 (CN) | Issued Sept. 26, 2012 | ||
Stent Apparatuses For Treatment Via Body Lumens And Methods Of Use | 2,609,687 (CA) | May 24, 2006; issued April 22, 2014 | ||
Stent Apparatuses For Treatment Via Body Lumens And Methods Of Use | 2,843,097 (CA) | Feb. 20, 2014; issued Oct. 27, 2015 | ||
Stent Apparatuses For Treatment Via Body Lumens And Methods Of Use | 2007/10751 (ZA) | Issued Oct. 27, 2010 | ||
Filter Assemblies | 198189 (IL) | Oct. 18, 2007; issued Mar. 27, 2014 |
Filter Assemblies | 2,666,712 (CA) | Oct. 18, 2007; issued Mar. 31, 2015 | ||
Filter Assemblies | ZL200780046659.9 (CN) | Oct. 18, 2007; issued Mar. 31, 2015 | ||
Filter Assemblies | 201210119132.7 (CN) | Oct. 18, 2007 | ||
Knitted Stent Jackets | 198190 (IL) | Oct. 18, 2007; issued Feb. 1, 2014 | ||
Knitted Stent Jackets | ZL200780046697.4 (CN) | Issued Oct. 10, 2012; expires Oct. 17, 2027 | ||
Knitted Stent Jackets | 2,666,728 (CA) | Oct. 18, 2007; issued June 23, 2015 | ||
Knitted Stent Jackets | ZL201210320950.3 (CN) | Oct. 18, 2007; issued Dec. 2, 2015 | ||
Stent with Sheath and Metal Wire | 14/315,001 (US); 2014/0309723 | June 25, 2014 | ||
Stent with Sheath and Metal Wire and Methods | 14/705,871 (US); 2015/0230953 | May 6, 2015 | ||
Optimized Stent Jacket | 12/791,008 (US); 2010/0241214 | June 1, 2010 | ||
Intravascular Aneurysm Treatment Device And Methods | 14/935,339 (US); 2016/0058589 | Nov. 6, 2015 | ||
Optimized Stent Jacket | 07827415.6 (EP); EP2088962 A4 | Nov. 21, 2007 | ||
Optimized Stent Jacket | 230922 (IL) | Feb. 11, 2014 | ||
Optimized Stent Jacket | 2,670,724 (CA) | Nov. 21, 2007 | ||
Optimized Stent Jacket | 4008/DELNP/2009 (IN) | Nov. 21, 2007 | ||
Optimized Drug-Eluting Stent Assembly | 14/851,882 (US); 2015/0374519 | Sept. 11, 2015 | ||
Bifurcated Stent Assemblies | 3113/DELNP/2009 (IN) | Oct. 18, 2007 | ||
Stent Apparatuses For Treatment Via Body Lumens And Methods Of Use | EP 06745069.2 (EP); EP1885281 A2 | May 24, 2006 |
Stent Apparatuses For Treatment Via Body Lumens And Methods Of Use | 11/920,972 (US); 2009/0138070 | Nov. 23, 2007 | ||
Stent Apparatuses For Treatment Via Body Lumens And Methods Of Use | 187516 (IL) | Nov. 20, 2007 | ||
Carotid Stent Assembly and Methods for Treatment Via Body Lumens | 14/500,759 (US); 2015/0032197 | Sept. 29, 2014 | ||
Filter Assemblies | EP 2007 827228.3 (EP) | Oct. 18, 2007 | ||
Filter Assemblies | 12/445,972 (US); 2010/0204772 | Apr. 17, 2009 | ||
Filter Assemblies | 2,881,557 (CA) | Feb. 6, 2015 | ||
Filter Assemblies | 3114/DELNP/2009 (IN) | Oct. 18, 2007 | ||
Knitted Stent Jackets | EP 07827229.1 (EP); EP ###-###-#### A2 | Oct. 18, 2005 | ||
Knitted Stent Jackets | 12/445,980 (US); 2010/0324651 | Apr. 17, 2009 | ||
Knitted Stent Jackets | 3171/DELNP/2009 (IN) | Oct. 18, 2007 | ||
Knitted Stent Jackets | 2,887,189 (CA) | Apr. 2, 2015 | ||
Stent Thermoforming Apparatus and Methods | 14/505,310 (US); 2016/0096308 | Oct. 2, 2014 | ||
Stent Thermoforming Apparatus and Methods | PCT/IB2015/057367 | Sept. 24, 2015 | ||
Stent-Mesh Assembly And Methods | 14/592,714 (US); 2015/0119971 | Jan. 8, 2015 | ||
Stent with Sheath and Metal Wire Retainer | 13/994,739 (US); 2013/0274858 | Dec. 18, 2011 | ||
Deformable Tip For Stent Delivery And Methods Of Use | 62/290,031 (US) | Feb. 2, 2016 |
[END OF EXHIBIT D]
Appendix E
Trademarks
Description | Registration/ Application Number (Country) | Registration/ Application Date | ||
CARENET | 013399977 (EU) | Mar. 17, 2015 | ||
CGUARD | 013370978 (EU) | Mar. 26, 2015 | ||
INSPIREMD | 008642118 (EU) | Apr. 26, 2010 | ||
MGUARD | 008642175 (EU) | Apr. 26, 2010 | ||
MGUARD PRIME | 013366141 (EU) | Mar. 12, 2015 | ||
MICRONET (Class 10) (Supplemental Registration) | 4,721,716 (US); 85/659,900 | Apr. 14, 2015 | ||
MNP MicroNet Protection Logo | 011737699 (EU) | Sept. 9, 2013 | ||
CARENET | 86/261,697 (US) | Apr. 24, 2014 | ||
CGuard | 86/364,984 (US) | Aug. 13, 2014 | ||
MGUARD PRIME | 86/417,711 (US) | Oct. 8, 2014 | ||
InspireMD | 86/702,932 (US) | July 23, 2015 | ||
SmartFit | 86/702,941 (US) | July 23, 2015 | ||
PVGuard | 86/702,984 (US) | July 23, 2015 | ||
NGuard | 86/702,957 (US) | July 23, 2015 | ||
AGuard | 86/702,971 (US) | July 23, 2015 |
Appendix F
Mask Works
None.
Appendix G
Equipment List
Distributed via e-mail.